0.0030
0.0000
(0.00%)
At close: 4:10:45 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-1,815.9370
-1,815.9370
-5,778.8220
-8,679.2130
-3,877.1570
Investing Cash Flow
1,006.7880
1,006.7880
1,000.0000
1,993.7090
-4,003.8870
Financing Cash Flow
4.2940
4.2940
6.4470
7,556.4230
11,051.5170
End Cash Position
2,240.6610
2,240.6610
3,045.5160
7,817.8410
6,916.6040
Capital Expenditure
-3.2360
-3.2360
--
-2.2890
-3.8870
Issuance of Capital Stock
4.2940
4.2940
6.4470
7,901.6250
11,687.7430
Repurchase of Capital Stock
--
--
--
-345.2020
-636.2260
Free Cash Flow
-1,819.1730
-1,819.1730
-5,778.8220
-8,681.5020
-3,881.0440
6/30/2021 - 7/13/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VBS.AX Vectus Biosystems Limited
0.0790
0.00%
RNV.AX RENERVE FPO [RNV]
0.1400
-3.45%
TRP.AX Tissue Repair Ltd
0.3050
+7.02%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0370
+2.78%
NYR.AX Nyrada Inc.
0.0740
-2.63%
ZLD.AX Zelira Therapeutics Limited
0.5500
+1.85%
PIQ.AX Proteomics International Laboratories Ltd
0.6450
-2.27%
PTX.AX Prescient Therapeutics Limited
0.0550
+1.85%
NOX.AX Noxopharm Limited
0.0900
-5.26%
SPL.AX Starpharma Holdings Limited
0.1050
0.00%